Optimising use of rate-of-change trend arrows for insulin dosing decisions using the FreeStyle Libre flash glucose monitoring system

被引:22
作者
Ajjan, Ramzi A. [1 ]
Cummings, Michael H. [2 ]
Jennings, Peter [3 ]
Leelarathna, Lalantha [4 ,5 ]
Rayman, Gerry [6 ]
Wilmot, Emma G. [3 ]
机构
[1] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England
[2] Queen Alexandra Hosp, Acad Dept Diabet & Endocrinol, Portsmouth, Hants, England
[3] Derby Teaching Hosp NHS Fdn Trust, Derby, England
[4] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Diabet Ctr, Manchester, Lancs, England
[5] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Fac Biol Med & Hlth, Manchester, Lancs, England
[6] Ipswich Hosp NHS Trust, Ctr Diabet, Ipswich, Suffolk, England
关键词
Continuous glucose monitoring; flash glucose monitoring; interstitial fluid; rate of change; trend arrow; insulin dosing; DIABETES MANAGEMENT; SENSING TECHNOLOGY; GLYCEMIC CONTROL;
D O I
10.1177/1479164118795252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Continuous glucose monitoring and flash glucose monitoring systems are increasingly used by people with diabetes on multiple daily injections of insulin and continuous subcutaneous insulin infusion. Along with real-time updates on current glucose levels, these technologies also use trend arrows to provide information on the direction and rate of change of glucose. Two systems, the Dexcom G5 and the FreeStyle Libre, have recently been approved for use without the need for adjunct capillary blood glucose, and there is a need for practical guidance for insulin dosing which incorporates rate of change in the insulin dosing algorithm. Here, we review the integration of rate of change trend arrow information into daily glucose management, including rapid-acting insulin dosing decisions. Based on the FreeStyle Libre flash glucose monitoring system, we also review a practical decision-support tool for actions to take when using trend arrows in conjunction with current glucose readings.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 18 条
[1]  
[Anonymous], 2017, PREM APPR APPL PMA N
[2]  
[Anonymous], 2015, TYP 1 DIAB AD DIAGN
[3]  
Association of Children's Diabetes Clinicians, REAL TIM FLASH GLUC
[4]   Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial [J].
Beck, Roy W. ;
Riddlesworth, Tonya ;
Ruedy, Katrina ;
Ahmann, Andrew ;
Bergenstal, Richard ;
Haller, Stacie ;
Kollman, Craig ;
Kruger, Davida ;
McGill, Janet B. ;
Polonsky, William ;
Toschi, Elena ;
Wolpert, Howard ;
Price, David .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04) :371-378
[5]   Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial [J].
Bolinder, Jan ;
Antuna, Ramiro ;
Geelhoed-Duijvestijn, Petronella ;
Kroeger, Jens ;
Weitgasser, Raimund .
LANCET, 2016, 388 (10057) :2254-2263
[6]   Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator) [J].
Buckingham, Bruce ;
Xing, Dongyuan ;
Weinzimer, Stu ;
Fiallo-Scharer, Rosanna ;
Kollman, Craig ;
Mauras, Nelly ;
Tsalikian, Eva ;
Tamborlane, William ;
Wysocki, Tim ;
Ruedy, Katrina ;
Beck, Roy .
PEDIATRIC DIABETES, 2008, 9 (02) :142-147
[7]   Timing of Meal Insulin Boluses to Achieve Optimal Postprandial Glycemic Control in Patients with Type 1 Diabetes [J].
Cobry, Erin ;
McFann, Kim ;
Messer, Laurel ;
Gage, Victoria ;
VanderWel, Brandon ;
Horton, Lauren ;
Chase, H. Peter .
DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (03) :173-177
[8]   Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes [J].
Haak, Thomas ;
Hanaire, Helene ;
Ajjan, Ramzi ;
Hermanns, Norbert ;
Riveline, Jean-Pierre ;
Rayman, Gerry .
DIABETES THERAPY, 2017, 8 (03) :573-586
[9]  
Heffernan E, 2015, END ABSTR, V39, pEP46, DOI 10.1530/endoabs.39.EP46
[10]   Sensor-augmented insulin pump therapy: Results of the first randomized treat-to-target study [J].
Hirsch, Irl B. ;
Abelseth, Jill ;
Bode, Bruce W. ;
Fischer, Jerome S. ;
Kaufman, Francine R. ;
Mastrototaro, John ;
Parkin, Christopher G. ;
Wolpert, Howard A. ;
Buckingham, Bruce A. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (05) :377-383